“…The M2 viroporin, a proton-dependent proton channel required for virus entry and egress, has historically been an effective antiviral target for drugs like amantadine and rimantadine. However, mutations in M2, 7-10, 12, 17-18, 22, 25), inhibit viruses with major resistance to other IAV antivirals like oseltamivir (5, 8, 10, 16) and/or synergize with oseltamivir (5, 16, 28), exhibit high genetic barriers to resistance following long-term in vitro passaging (5, 8, 14-16), have supportive preclinical parameters such as good stability and low toxicity (9, 16, 23), and rescue mice from lethal infection (9 Waters are shown as spheres (Thomaston et al, 2017). -S31N (19-49) in complex with (4) (PDB: 2LY0; ).…”